CVRX

CVRx, Inc.

Healthcare
Medical - Devices
$76M market cap

Forecast run · Sep 14, 2026Upside rank 169 of 3,136

Model Signal

ForecastQ Daily Probabilities

68.2%

33.1%

45.3%

Analyst Consensus

Recommendation2.43/5 Buy

Last price$2.88

Price target$4.13

Implied move+43.4%

Analysts7

ForecastQ Portfolios

CVRX is not in any ForecastQ portfolio today. The model scores it with every run; the names it picked are in Portfolios.

Company Profile

CVRx, Inc. is a commercial-stage medical technology company focused on innovating, producing, and bringing to market neuromodulation solutions designed for individuals battling cardiovascular diseases. Its principal offering, Barostim, is an advanced neuromodulation device specifically indicated to ameliorate symptoms for patients diagnosed with heart failure characterized by reduced ejection fraction, often referred to as systolic heart failure. The company employs a diverse distribution strategy, leveraging its internal sales force, alongside sales agents and independent distributors, to reach markets across the United States, Germany, the wider European continent, and other global territories. Incorporated in 2000, CVRx, Inc. is headquartered in Minneapolis, Minnesota.